A trend has emerged in the United States of more young and middle-age women being diagnosed with lung cancer at higher rates ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/90.Cmvv_fHs.js ...

With targeted treatment and a strong support group, she now lives a full life and serves the community that had her back.

The addition of tiragolumab to Tecentriq in patients with advanced PD-L1-high NSCLC failed to improve overall survival in a Phase III trial.

Bangalore: AstraZeneca Pharma India Limited has received permission to import for sale and distribution in Form CT-20 from ...

Both rare and aggressive, triple-negative breast cancer accounts for 10-15% of all breast cancers. Dr. Bhardwaj says, “TNBC ...

Data include the use of FINTEPLA® (fenfluramine)1 oral solution in seizures associated with Dravet syndrome and Lennox-Gastaut ...